The past week's trades have shown a mixed strategy with substantial purchases and sales across ARK's funds. On Thursday, 10 April, ARKK made large acquisitions, including 135,247 shares of Beam Therapeutics Inc (NASDAQ: BEAM ) and 118,49 shares of Coinbase Global Inc (NASDAQ: COIN ), indicating a strong interest in these companies. Meanwhile, the consistent selling of Repare Therapeutics suggests a bearish outlook on the pharmaceutical company.